May 2021

Natco Pharma Limited has received Emergency Use approval for Baricitinib tablets, 1mg, 2mg and 4mg strengths from Central Drugs Standard Control Organization (CDSCO) in India. Baricitinib in combination with Remdesivir, is used for treatment of COVID-19 positive patients.

Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, announced the launch of Ryaltris - AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India. Glenmark being one of the leaders in respiratory segment, has been the first to launch the branded generic version at an affordable cost for the treatment of allergic rhinitis in India. This will provide patients a far more convenient, cost effective treatment option in the country.

A Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center found that BK virus (BKV)-specific T cells from healthy donors were safe and effective as an off-the-shelf therapy for BKV-associated hemorrhagic cystitis (BKV-HC), a painful complication common after allogeneic stem cell transplants for patients with leukemia or lymphoma. The study was published today in the Journal of Clinical Oncology.

Customised medicines could one day be manufactured to patients' individual needs, with University of East Anglia (UEA) researchers investigating technology to 3D 'print' pills.

The team, including Dr Andy Gleadall and Prof Richard Bibb at Loughborough University, identified a new additive manufacturing method to allow the 3D printing of medicine in highly porous structures, which can be used to regulate the rate of drug release from the medicine to the body when taken orally.

Daiichi Sankyo Company, Limited announced that it has entered into an exclusive licensing agreement (hereinafter, the Agreement) with Esperion Therapeutics, Inc.  to market bempedoic acid, their proprietary oral once-daily drug for the treatment of hypercholesterolemia, in South Korea, Brazil, Taiwan, Hong Kong, Macao, Thailand, Vietnam, Myanmar and Cambodia .

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that they have submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) seeking approval of cilta-cel, an investigational B cell maturation antigen (BCMA)-directed chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients with relapsed and/or refractory multiple myeloma.

National Agri-Food Biotechnology Institute (NABI) is an autonomous Institute under Department of Biotechnology, Government of India. NABI aims at catalysing the transformation of Agri-food sector in India by being a nodal organization for knowledge generation and translational science leading to value-added products based on Agri-Food biotech innovations for improved household nutritional security. Since its inception in 2010, NABI is involved in research activities for the Bio fortification, development of designer crops for improved nutrition, providing sustainable and novel solutions towards quality food and nutrition, and development of evidence based functional foods to counter malnutrition. Food and nutritional Biotechnology division at NABI requires following research personnel purely on temporary basis.

Post: Research Associate

Rashtriya Bal Swasthya Karyakram (RBSK) is an important initiative aiming at early identification and early intervention for children from birth to 18 years to cover 4 viz. Defects at birth, Deficiencies, Diseases, Development delays including disability.

Post : Pharmacist - 03 posts

Recruitment process for Covid Care Center (CCC), Dedicated Covid Health Center (DCHC), Dedicated Covid Hospital (DCH) operating under Covid 19 in Solapur District and to be established in future. Interview system is being implemented from District Surgeon's Office, Solapur.  However, the details of the required posts are as follows.